4Q9Z | Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE) | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Argiriadi, M.A., George, D.M. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 | ||||||||||||
ligand | NA, PZW, SEP | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of Selective and Orally Bioavailable Protein Kinase Ctheta (PKCtheta) Inhibitors from a Fragment Hit., George DM, Breinlinger EC, Friedman M, Zhang Y, Wang J, Argiriadi M, Bansal-Pakala P, Barth M, Duignan DB, Honore P, Lang Q, Mittelstadt S, Potin D, Rundell L, Edmunds JJ, J Med Chem. 2014 Jul 7. PMID:25000588 |
Data retrieval |
View 4Q9Z in 3D |
Visual 3D analysis of 4Q9Z |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4Q9Z |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |